+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Proton Therapy Market - Global Forecast 2026-2032- Product Image
Proton Therapy Market - Global Forecast 2026-2032- Product Image
New

Proton Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674719
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global proton therapy market is evolving rapidly, presenting health systems with advanced radiotherapy solutions uniquely positioned at the crossroads of innovation, clinical benefit, and operational complexity. Senior healthcare executives are increasingly seeking rigorous insights to inform investments and strategic deployments of proton therapy programs.

Market Snapshot: Proton Therapy Market Overview

The Proton Therapy Market grew from USD 620.33 million in 2025 to USD 685.96 million in 2026. It is expected to continue growing at a CAGR of 11.43%, reaching USD 1.32 billion by 2032.

Scope & Segmentation

  • Technology Architectures: Cyclotron-based and synchrotron-based systems accommodate distinct facility needs, with compact designs reducing installation barriers and offering scalable deployment across diverse footprints.
  • Delivery Approaches: Fixed beam and gantry-based systems each support different clinical and operational priorities, influencing both workflow design and patient throughput.
  • Clinical Applications: Oncology remains the primary segment, supported by expanding use for pediatric, neurological, cardiovascular, and ocular interventions where precision radiation is critical.
  • End-User Profiles: Hospitals, ambulatory care centers, research institutes, and specialty clinics each adopt customized business models, integration strategies, and referral pathways to optimize investment and patient outcomes.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting variable regulatory environments, infrastructure maturity, and payer landscapes.

Key Takeaways for Senior Decision-Makers

  • Proton therapy, once a niche solution, is becoming a relevant option for complex radiotherapy needs due to ongoing technology enhancements and accumulating clinical experience.
  • Adoption decisions must consider significant capital requirements, operational readiness, and a dynamic payer landscape, as reimbursement expectations continue to evolve.
  • Innovations in compact cyclotrons and modular system design enable more flexible facility planning while helping organizations manage procurement and construction timelines.
  • Increasing focus on data-driven, real-world clinical outcomes is influencing referral patterns and payer engagement, prompting health systems to establish standardized protocols and registries.
  • Non-oncology indications and pediatric cases are driving demand for tissue-sparing precision, requiring cross-disciplinary collaboration to develop care pathways and outcome measures.
  • Strategic partnerships, including local manufacturing and managed service agreements, are core to addressing equipment lifecycle support and operational sustainability.

Tariff Impact on Supply Chain and Procurement

Changes in tariff policy directly shape procurement cycles and pricing within the proton therapy market. Internationally sourced system components expose capital investments to regulatory flux, leading to extended negotiation, increased lead times, and potentially phased deployments. Vendors and health systems increasingly favor domestic assembly and modular design strategies to limit trade vulnerability and stabilize parts supply. Effective procurement planning now integrates risk mitigation through supplier diversification and contract protections against tariff-driven disruptions, ensuring that construction and commissioning remain aligned with service delivery goals.

Methodology & Data Sources

This research leverages a blend of primary interviews with clinicians, hospital procurement officers, and engineers, alongside comprehensive analysis of peer-reviewed literature, regulatory documents, procurement records, and technical specifications. Insights are validated through triangulation with published case studies and cross-sector stakeholder input, ensuring an accurate and contemporary view of the market landscape.

Why This Report Matters

  • Provides senior executives with actionable frameworks to de-risk deployment, optimize technology selection, and build multidisciplinary partnerships for clinical excellence.
  • Guides finance and operations leaders as they navigate evolving payer and regulatory landscapes, capital project planning, and long-term service arrangements.
  • Enables procurement and clinical teams to benchmark strategy and forecast future demand in an environment shaped by innovation, policy shifts, and patient-centered metrics.

Conclusion

Proton therapy adoption depends on aligning technology fit, clinical evidence, and robust operational planning. Institutions that integrate these factors effectively can establish sustainable programs with strong clinical and business outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Proton Therapy Market, by Technology
8.1. Cyclotron
8.2. Synchrotron
9. Proton Therapy Market, by Delivery Model
9.1. Fixed Beam
9.2. Gantry Based
10. Proton Therapy Market, by Application
10.1. Non Oncology
10.1.1. Cardiovascular Disorders
10.1.2. Neurological Disorders
10.1.3. Ocular Disorders
10.2. Oncology
11. Proton Therapy Market, by End User
11.1. Ambulatory Care Centers
11.2. Hospitals
11.3. Research Institutes
11.4. Specialty Clinics
12. Proton Therapy Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Proton Therapy Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Proton Therapy Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Proton Therapy Market
16. China Proton Therapy Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Advanced Oncotherapy plc
17.6. Hitachi, Ltd.
17.7. Ion Beam Applications S.A.
17.8. Mevion Medical Systems
17.9. Mitsubishi Heavy Industries, Ltd.
17.10. ProNova Solutions LLC
17.11. ProTom International, Inc.
17.12. RaySearch Laboratories
17.13. Siemens Healthineers AG
17.14. Sumitomo Heavy Industries, Ltd.
17.15. Toshiba Corporation
17.16. Varian Medical Systems, Inc.
List of Figures
FIGURE 1. GLOBAL PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PROTON THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PROTON THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PROTON THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PROTON THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PROTON THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PROTON THERAPY MARKET SIZE, BY CYCLOTRON, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PROTON THERAPY MARKET SIZE, BY CYCLOTRON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PROTON THERAPY MARKET SIZE, BY CYCLOTRON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PROTON THERAPY MARKET SIZE, BY SYNCHROTRON, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PROTON THERAPY MARKET SIZE, BY SYNCHROTRON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PROTON THERAPY MARKET SIZE, BY SYNCHROTRON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PROTON THERAPY MARKET SIZE, BY FIXED BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PROTON THERAPY MARKET SIZE, BY FIXED BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PROTON THERAPY MARKET SIZE, BY FIXED BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PROTON THERAPY MARKET SIZE, BY GANTRY BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PROTON THERAPY MARKET SIZE, BY GANTRY BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PROTON THERAPY MARKET SIZE, BY GANTRY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PROTON THERAPY MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PROTON THERAPY MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PROTON THERAPY MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PROTON THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PROTON THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PROTON THERAPY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PROTON THERAPY MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PROTON THERAPY MARKET SIZE, BY OCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PROTON THERAPY MARKET SIZE, BY OCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PROTON THERAPY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PROTON THERAPY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PROTON THERAPY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PROTON THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PROTON THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PROTON THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PROTON THERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PROTON THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PROTON THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PROTON THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PROTON THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PROTON THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. AMERICAS PROTON THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 48. AMERICAS PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 71. EUROPE PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. EUROPE PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 73. EUROPE PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 74. EUROPE PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 76. EUROPE PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 82. MIDDLE EAST PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. AFRICA PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. AFRICA PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 85. AFRICA PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 86. AFRICA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. AFRICA PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 88. AFRICA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PROTON THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. ASEAN PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. ASEAN PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. ASEAN PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 99. ASEAN PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. ASEAN PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 101. ASEAN PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. GCC PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GCC PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. GCC PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 105. GCC PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. GCC PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 107. GCC PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 111. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 113. EUROPEAN UNION PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. BRICS PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. BRICS PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. BRICS PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 117. BRICS PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. BRICS PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 119. BRICS PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. G7 PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. G7 PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. G7 PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 123. G7 PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. G7 PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 125. G7 PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. NATO PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. NATO PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. NATO PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 129. NATO PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. NATO PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 131. NATO PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PROTON THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. UNITED STATES PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 134. UNITED STATES PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. UNITED STATES PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 136. UNITED STATES PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. UNITED STATES PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 138. UNITED STATES PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. CHINA PROTON THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. CHINA PROTON THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. CHINA PROTON THERAPY MARKET SIZE, BY DELIVERY MODEL, 2018-2032 (USD MILLION)
TABLE 142. CHINA PROTON THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. CHINA PROTON THERAPY MARKET SIZE, BY NON ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 144. CHINA PROTON THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Proton Therapy market report include:
  • Advanced Oncotherapy plc
  • Hitachi, Ltd.
  • Ion Beam Applications S.A.
  • Mevion Medical Systems
  • Mitsubishi Heavy Industries, Ltd.
  • ProNova Solutions LLC
  • ProTom International, Inc.
  • RaySearch Laboratories
  • Siemens Healthineers AG
  • Sumitomo Heavy Industries, Ltd.
  • Toshiba Corporation
  • Varian Medical Systems, Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 685.96 Million
Forecasted Market Value ( USD ) by 2032 $ 1320 Million
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Proton Therapy System for Cancer Market - Global Forecast 2026-2032 - Product Image

Proton Therapy System for Cancer Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Proton Therapy Equipment Market - Global Forecast 2025-2032 - Product Image

Proton Therapy Equipment Market - Global Forecast 2025-2032

  • Report
  • 186 Pages
  • Global
From
Proton Therapy Market Report and Forecast 2025-2034 - Product Image

Proton Therapy Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Proton Therapy Systems Market - Product Image

Proton Therapy Systems Market

  • Report
  • 150 Pages
  • Global
From
Proton Therapy Accelerator Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Proton Therapy Accelerator Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Market

Proton Therapy is a form of radiation therapy used in Nuclear Medicine and Radiopharmacology. It is a type of particle therapy that uses protons, rather than X-rays, to treat cancer. Protons are positively charged particles that can be precisely targeted to tumors, minimizing damage to surrounding healthy tissue. This makes Proton Therapy an attractive option for treating tumors in sensitive areas, such as the brain, spine, and eyes. It is also used to treat tumors that are difficult to reach with traditional radiation therapy. Proton Therapy is a rapidly growing field, with many companies offering services and equipment. Examples include Varian Medical Systems, IBA, Hitachi, ProTom International, and Mevion Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.